Libtayo 350 mg (Cemiplimab SOLUTION) 350 MG

Libtayo 350 mg is a solution for intravenous use, containing the active ingredient cemiplimab. This medication is used in cancer treatment and is manufactured by Regeneron Canada Company.

Strength

350 MG

Manufacturer / TM Owner

REGENERON CANADA COMPANY

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Libtayo 350 mg is primarily used in the treatment of certain types of cancer. It works by targeting specific cells in the body to help the immune system fight cancer cells. This medication is often prescribed for advanced or metastatic cancers where other treatments have not been effective. Patients should consult their healthcare provider to determine if Libtayo is suitable for their specific condition.

Side Effects

Common effects of Libtayo 350 mg may include fatigue, rash, and diarrhea. Some patients may also experience nausea, itching, or swelling at the injection site. These effects vary from person to person and are not experienced by everyone who takes the medication. It is important to report any severe or persistent side effects to a healthcare professional.

Precautions & Warnings

Libtayo 350 mg should be handled with care and administered by a healthcare professional. It is important to inform your doctor about any allergies or medical conditions before starting treatment. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider. Always follow the prescribed dosage and administration instructions provided by your healthcare team.

Avoid Interactions

Libtayo 350 mg may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Alcohol consumption should be discussed with your doctor, as it may affect the effectiveness or safety of the treatment.

Frequently Asked Questions

Libtayo 350 mg is used in the treatment of certain types of cancer, particularly advanced or metastatic cancers where other treatments have not been effective.

Libtayo 350 mg is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, rash, diarrhea, nausea, itching, or swelling at the injection site.

It is important to inform your healthcare provider about all medications you are taking, as Libtayo 350 mg may interact with other drugs.

Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider before starting Libtayo 350 mg.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.